Skip to content
10-Q

Quarterly Report

Mersana Therapeutics, Inc.

0001628280-25-040017

← back to feed
Filed
Aug 13, 2025 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Aug 8, 2025 4.99M sh
Shares Diluted Q2 2025 · Jun 30, 2025 4.99M sh
Shares Diluted Q2 2025 · Jun 30, 2025 4.98M sh
Shares Diluted restated Q2 2025 · Jun 30, 2024 4.9M sh
Shares Diluted restated Q2 2025 · Jun 30, 2024 4.88M sh
Capex Q2 2025 · Jun 30, 2025 $0
Capex Q2 2025 · Jun 30, 2024 $132K
Operating Cash Flow Q2 2025 · Jun 30, 2025 −$51.93M
Operating Cash Flow Q2 2025 · Jun 30, 2024 −$54.51M
Long Term Debt Q2 2025 · Jun 30, 2025 $0
Long Term Debt Q2 2025 · Dec 31, 2024 $10.95M
Cash And Equivalents Q2 2025 · Jun 30, 2025 $76.97M
Cash And Equivalents Q2 2025 · Dec 31, 2024 $107.75M
Cash And Equivalents Q2 2025 · Jun 30, 2024 $59M
Cash And Equivalents Q2 2025 · Dec 31, 2023 $174.56M
Stockholders Equity Q2 2025 · Jun 30, 2025 −$53.15M
Stockholders Equity Q2 2025 · Mar 31, 2025 −$30.87M
Stockholders Equity Q2 2025 · Dec 31, 2024 −$9.51M
Stockholders Equity Q2 2025 · Jun 30, 2024 $8.43M
Stockholders Equity Q2 2025 · Mar 31, 2024 $27.99M
Stockholders Equity Q2 2025 · Dec 31, 2023 $36.9M
Current Liabilities Q2 2025 · Jun 30, 2025 $59.34M
Current Liabilities Q2 2025 · Dec 31, 2024 $62.46M
Total Liabilities Q2 2025 · Jun 30, 2025 $137.72M
Total Liabilities Q2 2025 · Dec 31, 2024 $154.17M
Current Assets Q2 2025 · Jun 30, 2025 $80.14M
Current Assets Q2 2025 · Dec 31, 2024 $136.9M
Total Assets Q2 2025 · Jun 30, 2025 $84.57M
Total Assets Q2 2025 · Dec 31, 2024 $144.66M
Eps Diluted Q2 2025 · Jun 30, 2025 −$4.87
Eps Diluted Q2 2025 · Jun 30, 2025 −$9.72
Eps Diluted restated Q2 2025 · Jun 30, 2024 −$4.96
Eps Diluted restated Q2 2025 · Jun 30, 2024 −$8.93
Eps Basic Q2 2025 · Jun 30, 2025 −$4.87
Eps Basic Q2 2025 · Jun 30, 2025 −$9.72
Eps Basic restated Q2 2025 · Jun 30, 2024 −$4.96
Eps Basic restated Q2 2025 · Jun 30, 2024 −$8.93
Sga Expense Q2 2025 · Jun 30, 2025 $7.42M
Sga Expense Q2 2025 · Jun 30, 2025 $16.34M
Sga Expense Q2 2025 · Jun 30, 2024 $10.5M
Sga Expense Q2 2025 · Jun 30, 2024 $22.06M
Rd Expense Q2 2025 · Jun 30, 2025 $16.22M
Rd Expense Q2 2025 · Jun 30, 2025 $34.56M
Rd Expense Q2 2025 · Jun 30, 2024 $17.25M
Rd Expense Q2 2025 · Jun 30, 2024 $35.93M
Net Income Q2 2025 · Jun 30, 2025 −$24.3M
Net Income Q2 2025 · Jun 30, 2025 −$48.42M
Net Income Q2 2025 · Mar 31, 2025 −$24.12M
Net Income Q2 2025 · Jun 30, 2024 −$24.27M
Net Income Q2 2025 · Jun 30, 2024 −$43.57M
Net Income Q2 2025 · Mar 31, 2024 −$19.31M
Revenue Q2 2025 · Jun 30, 2025 $3.06M
Revenue Q2 2025 · Jun 30, 2025 $5.81M
Revenue Q2 2025 · Jun 30, 2024 $2.29M
Revenue Q2 2025 · Jun 30, 2024 $11.54M